期刊文献+

如何制定临床试验数据与安全监察委员会章程 被引量:2

How to develop charter for clinical trial data and safety monitoring board
原文传递
导出
摘要 我国的随机对照临床试验中越来越多设立数据和安全监察委员会(DSMB),但在组织和操作过程中缺少具体的法规指导和支持。本文结合国际指南、文献、实践经验,设计数据和安全监察委员会章程,内容包括:简介、专家组成、责职、会议纪要、递交给DSMB的报告、DSMB建议及文件存档等,并提供模板文件供业界参考。 The data and safety monitoring board (DSMB) from randomized controlled trials (RCTs) is becoming more common in our country, but with little guidance on how they should operate. We develop a charter template for DSMB in clinical trial on the basis of international guidelines, literature and our experience for reference. The content includes introduction, composition, responsibility, minutes of meeting, communication reports to DSMB, recommendations of DSMB, document retention and so on.
作者 何迎春 吕映华 杨娟 HE Ying-chun LU Ying-hua YANG Juan(Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, SHANGHAI 201203, China)
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2016年第9期643-648,共6页 Chinese Journal of New Drugs and Clinical Remedies
基金 上海市中医药事业发展计划(ZY3-CCCX-3-1001) 上海市教委预算内项目(2013JW19 2014YSN17) 中药学创新研究基金项目(ZYX-CXYJ-003)
关键词 临床试验 管理委员会 章程和细则 clinical trial governing board constitution and bylaws
  • 相关文献

参考文献8

  • 1WHO. Operational guidelines for the establishment and functioning of data and safety monitoring boards. [EB/OL]. (2005-03-01) [2016 -02 - 18].http ://osp.od.nih.gov/sites/defauh/files/resources/ operational-guidelines.pdf.
  • 2FDA. Guidance for clinical trial sponsors: establishment and operation of clinical trial data monitoring committees. [EB/OL]. ( 2006 - 03 - 01 ) [ 2016 - 03 - 18 ]. http : / / www. fda. gov / OHRMS / DOCKETS/98fr/O1 d-0489- gdl0003.pdf.
  • 3EMEA. Guideline on data monitoring committees. [EB/OL]. (2005 -07-27) [2016-02-18].http ://www.ema.europa.eu/docs/ en_GB/document library/Scientific guideline/2009/09/WC50000 3635.pdf.
  • 4DAMOCLES Study Group, NHS health technology assessment programme. A proposed charter for clinical trial data monitoring committees; helping them do their job well[J]. Lancet, 2005,365(9460) : 711-722.
  • 5CHALMERS I, ALTMAN DG, MCHAFFIE H, et al. Data sharing among data monitoring committees and responsibilities to patients and science[J]. Trials, 2013, 14: 102.
  • 6ZANNAD F, GATTIS STOUGH W, MCMURRAY J J, et aL When to stop a clinical trial early for benefit: lessons learned and future approaches[J]. Circ Heart Fail, 2012, 5(2): 294- 302.
  • 7ZUCKERMAN J, van der SCHAL1E B, CAHILK. Developing training for data safety monitoring board members: a national institute of allergy and infectious diseases case study[J]. Clin Trials, 2015, 12(6): 688-691.
  • 8WrFFES J, SCHACTMAN M. On independent data monitoring committees in oncology clinical trials[J]. Chin Clin Oncol, 2014, 3(2): 40.

同被引文献10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部